Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Melanoma, Secondary cancers
Closed
Pilot
This trial is looking at whether measuring can help doctors work out the best time to switch treatment for people with melanoma.
It is for people who:
can’t have surgery to remove the melanoma or it has spread elsewhere in the body and
have melanoma cells with a specific gene change in the BRAF gene called BRAF VE 600
Recruitment start: 2 May 2019
Recruitment end: 30 September 2022
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Paul Lorigan
Bristol-Myers Squibb
The Christie NHS Foundation Trust
University of Manchester
Last reviewed: 12 October 2023
CRUK internal database number: 17883